https://www.selleckchem.com/products/tvb-3166.html
In particular, no CAS displacement was registered, compared to a 28% ETS malfunction (either displacement or occlusion). The POPF rate, major morbidity, and mortality were 11%, 6%, and 0% respectively. The CAS positioning appears to be a feasible and safe mitigation strategy to secure PJ anastomosis after PD with high POPF risk avoiding stent displacement. Further validation and comparison with current standard of care is required in a prospective controlled setting. The CAS positioning appears to be a feasible and safe mitigation stra
Gefällt mir
Kommentar
Teilen
